Irvington-NY based Electro-Optical Sciences (EOS), developer of The MelaFind System, a handheld imaging device that detects melanomas at an early stage, announced last week that its pivotal trial is over two-thirds complete. […]
AngioDynamics Technology Not Responsible for Lung Tumor Treatment Deaths
In February 2003, the FDA’s General and Plastic Surgery Devices Advisory Committee met and discussed thermal ablation of lung tumors. Concerns were raised about the safety and adverse event reporting associated with […]
EDAP TMS’ Ablatherm Study Relevant to FDA Clinical Investigation
High Intensity Focused Ultrasound (HIFU) is competitive with currently accepted non-surgical standards of care, such as radiotherapy, but results in milder side effects, reveals the first long-term study of HIFU for the […]
Rockland Technimed: Tissue Viability Imaging
Early detection of ischemic injury, though difficult to achieve, is becoming increasingly critical to the proper utilization of new interventional procedures. Experts note that although Magnetic Resonance Angiography can evaluate vessel anatomy […]
[Video] Interview with Kathryn Tunstall, Chairman of NeoMatrix
Irvine, California-based NeoMatrix offers the HALO Breast Pap Test, a fully automated, noninvasive breast disease screening device designed for use in a primary care setting. HALO is FDA approved for the collection […]
Luminex Targets Growing Area of Gene Research with FlexmiR Select
FlexmiR Select, a new assay designed by Luminex, will allow researchers to improve their analysis of microRNAs (miRNA) – single-stranded RNA molecules which regulate gene expression. FlexmiR Select allows researchers to create […]
[Video] Interview with Joseph Gulfo, President and CEO of Electro-Optical Sciences
We gathered this footage back in September at the Think Equity G5 Growth Conference. In this segment, Gulfo discusses MelaFind – a handheld device that capture images of suspicious pigmented skin lesions. […]
Stock Offering Fuels Inverness’ Thirst for Acquisition
Buoyed by a recent stock offering, the Inverness Medical machine continues to gobble up companies as they consolidate the disease and health management service space. The most recent acquisition of ParadigmHealth will […]
